AAAAAA
Results:
1-21
|
Results: 21
Authors:
Charlwood, JD
Clarke, SE
Bogh, C
Citation: Jd. Charlwood et al., Costing vaccines versus bednets, TRENDS PARA, 17(3), 2001, pp. 121-121
Authors:
Clarke, SE
Citation: Se. Clarke, Globalization, democratic governance, and local politics, URBAN AFF R, 37(1), 2001, pp. 148-151
Authors:
Bromidge, SM
Clarke, SE
Gager, T
Griffith, K
Jeffrey, P
Jennings, AJ
Joiner, GF
King, FD
Lovell, PJ
Moss, SF
Newman, H
Riley, G
Rogers, D
Routledge, C
Serafinowska, H
Smith, DR
Citation: Sm. Bromidge et al., Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: Identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134), BIOORG MED, 11(1), 2001, pp. 55-58
Authors:
Clarke, SE
Citation: Se. Clarke, Response - Well, maybe... : Taking context seriously in analyzing local economic development, ECON DEV Q, 15(4), 2001, pp. 320-322
Authors:
Clarke, SE
Wilder, MG
Citation: Se. Clarke et Mg. Wilder, Cities in the new millennium: Separate realities - Or shared fates? Introduction, J URBAN AFF, 23(2), 2001, pp. NIL_5-NIL_9
Authors:
Kenworthy, KE
Clarke, SE
Andrews, J
Houston, JB
Citation: Ke. Kenworthy et al., Multisite kinetic models for CYP3A4: Simultaneous activation and inhibition of diazepam and testosterone metabolism, DRUG META D, 29(12), 2001, pp. 1644-1651
Authors:
Clarke, SE
Jeffrey, P
Citation: Se. Clarke et P. Jeffrey, Utility of metabolic stability screening: comparison of in vitro and in vivo clearance, XENOBIOTICA, 31(8-9), 2001, pp. 591-598
Authors:
Clarke, SE
Bogh, C
Brown, RC
Pinder, M
Walraven, GEL
Lindsay, SW
Citation: Se. Clarke et al., Do untreated bednets protect against malaria?, T RS TROP M, 95(5), 2001, pp. 457-462
Authors:
Clarke, SE
Citation: Se. Clarke, Power and city governance: Comparative perspectives on urban on governance., J POLIT, 63(1), 2001, pp. 344-346
Authors:
Bogh, C
Clarke, SE
Pinder, M
Sanyang, F
Lindsay, SW
Citation: C. Bogh et al., Effect of passive zooprophylaxis on malaria transmission in the Gambia, J MED ENT, 38(6), 2001, pp. 822-828
Authors:
Deeni, YY
Paine, MJI
Ayrton, AD
Clarke, SE
Chenery, R
Wolf, CR
Citation: Yy. Deeni et al., Expression, purification, and biochemical characterization of a human cytochrome P450CYP2D6-NADPH cytochrome P450 reductase fusion protein, ARCH BIOCH, 396(1), 2001, pp. 16-24
Authors:
McIntosh, BA
Sedell, JR
Thurow, RF
Clarke, SE
Chandler, GL
Citation: Ba. Mcintosh et al., Historical changes in pool habitats in the Columbia River Basin, ECOL APPL, 10(5), 2000, pp. 1478-1496
Authors:
Clarke, SE
Guy, PL
Jameson, PE
Schmierer, D
Burritt, DJ
Citation: Se. Clarke et al., Influence of white clover mosaic potexvirus infection on the endogenous levels of jasmonic acid and related compounds in Phaseolus vulgaris L. seedlings, J PLANT PHY, 156(4), 2000, pp. 433-437
Comparison of two blood pool contrast agents for 0.5-T MR angiography: Experimental study in rabbits
Authors:
Clarke, SE
Weinmann, HJ
Dai, EB
Lucas, AR
Rutt, BK
Citation: Se. Clarke et al., Comparison of two blood pool contrast agents for 0.5-T MR angiography: Experimental study in rabbits, RADIOLOGY, 214(3), 2000, pp. 787-794
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gaster, LM
Ham, P
Jones, GE
King, FD
Mulholland, KR
Saunders, DV
Wyman, PA
Blaney, FE
Clarke, SE
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Trail, B
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134
Authors:
Routledge, C
Bromidge, SM
Moss, SF
Price, GW
Hirst, W
Newman, H
Riley, G
Gager, T
Stean, T
Upton, N
Clarke, SE
Brown, AM
Middlemiss, DN
Citation: C. Routledge et al., Characterization of SB-271046: A potent, selective and orally active 5-HT6receptor antagonist, BR J PHARM, 130(7), 2000, pp. 1606-1612
Authors:
Kenworthy, KE
Bloomer, JC
Clarke, SE
Houston, JB
Citation: Ke. Kenworthy et al., CYP3A4 drug interactions: correlation of 10 in vitro probe substrates, BR J CL PH, 48(5), 1999, pp. 716-727
Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone
Authors:
Baldwin, SJ
Clarke, SE
Chenery, RJ
Citation: Sj. Baldwin et al., Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone, BR J CL PH, 48(3), 1999, pp. 424-432
Authors:
Jordan, CGM
Rashidi, MR
Laljee, H
Clarke, SE
Brown, JE
Beedham, C
Citation: Cgm. Jordan et al., Aldehyde oxidase-catalysed oxidation of methotrexate in the liver of guinea-pig, rabbit and man, J PHARM PHA, 51(4), 1999, pp. 411-418
Authors:
Bromidge, SM
Brown, AM
Clarke, SE
Dodgson, K
Gager, T
Grassam, HL
Jeffrey, PM
Joiner, GF
King, FD
Middlemiss, DN
Moss, SF
Newman, H
Riley, G
Routledge, C
Wyman, P
Citation: Sm. Bromidge et al., 5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): A potent, selective, and orally bioavailable 5-HT6 receptor antagonist, J MED CHEM, 42(2), 1999, pp. 202-205
Authors:
Clarke, SE
Citation: Se. Clarke, In vitro assessment of human cytochrome P450, XENOBIOTICA, 28(12), 1998, pp. 1167-1202
Risultati:
1-21
|